Last Friday was National Celiac Disease (CeD) Awareness Day, but the need for awareness continues. We stand with the global community in raising awareness about CeD, an autoimmune condition affecting millions worldwide. CeD is often misunderstood, but it is vital to recognize its significance. This serious autoimmune disorder occurs when the ingestion of gluten—a protein found in wheat, barley, and rye—triggers an immune response in the small intestine. This response can damage the intestinal lining, leading to nutrient malabsorption and a range of severe health complications. Currently, management of the disease relies solely on a strict gluten-free diet. As this video from the Celiac Disease Foundation highlights, ongoing research is critical to finding better treatments. At Topas, we are utilizing our highly differentiated and versatile nanoparticle technology platform to develop a broad pipeline of novel therapies to treat autoimmune and antigen-driven diseases, including CeD. We currently have an ongoing Ph2a study in CeD, with results expected later this year. #CeliacDiseaseAwareness #NationalCeliacDiseaseAwarenessDay
Happy birthday to Dr. Samuel Gee, the pioneer who first linked diet to celiac disease! 🎉 Thanks to his groundbreaking work, millions now thrive on a gluten-free diet. At the Celiac Disease Foundation, we continue his legacy by providing resources, support, and research to help people with celiac disease live healthier lives. #CeliacDisease #SamuelGee #GlutenFreeLife #CeliacAwareness #ThrivingWithCeliac #GlutenFree #AutoimmuneDisease #CeliacSupport #CeliacResearch #LivingGlutenFree #GutHealth #CeliacCommunity #glutenfree
